Zobrazeno 1 - 4
of 4
pro vyhledávání: '"329"'
Autor:
A Rios, JM Rodriguez-Fernandez, Rocío Parody, M Morey, Ayats R, Rozman C, Emili Montserrat, T Vallespi, Prados D, F Gomis
Publikováno v:
Blood. 64(3)
In previous studies, the prognostic value of bone marrow (BM) histologic patterns in chronic lymphocytic leukemia (CLL) has been demonstrated. In order to investigate whether such a value is independent of other prognostic parameters, a multivariate
Autor:
Pablo J. Muxi, Bjorn Andreasson, Peter L. Johansson, Robyn M. Scherber, Dana Ranta, Stefanie Slot, Heidi E. Kosiorek, Dolores Hernández-Maraver, Amylou C. Dueck, Xiujuan Sun, Martin Griesshammer, Ana Kerguelen Fuentes, Peihong Zhang, Francesco Passamonti, Holly L. Geyer, Federico Sackmann, Zefeng Xu, Gabriel Etienne, Deepti Radia, Frank Stegelmann, Andreas Reiter, Tiziano Barbui, Jean-Christophe Ianotto, Suzan Commandeur, Peter A. W. te Boekhorst, Zhijian Xiao, Sonja Zweegman, Harry C. Schouten, Gunnar Birgegård, Carlos Besses, Françoise Boyer, Giovanni Barosi, Ruben A. Mesa, Alessandro Rambaldi, Jean-Jacques Kiladjian, Maria Grazia Ferrari, Thomas Lehmann, Heike L. Pahl, Lydia Roy, Jan Samuelsson, Francisco Cervantes, Alessandro M. Vannucchi, Konstanze Döhner, Yue Zhang, Karin Bonatz, Junqing Xu, Robert Peter Gale, Norman Maldonado, Jean-Yves Cahn, Claire N. Harrison
Publikováno v:
Blood. 126:4080-4080
Background Myelofibrosis (MF) is a clonal myeloproliferative neoplasm (MPN) associated with a high degree of symptomatology, progressive cytopenias and potential to transform into acute myelogenous leukemia (AML). Thrombocytopenia amongst MF patients
Autor:
Lucia Masarova, Taghi Manshouri, Sherry Pierce, Prithviraj Bose, Naveen Pemmaraju, Srdan Verstovsek, Naval Daver, Hagop M. Kantarjian, Jorge E. Cortes
Publikováno v:
Blood. 126:4069-4069
Introduction: Clinical characteristics of post-essential thrombocythemia/polycythemia vera myelofibrosis "post ET/PV-MF" are not well defined as for primary myelofibrosis "MF". Objective: We aimed to identify morphological, clinical and prognostic ch
Autor:
Jason Gotlib, Caramazza Domenica, Lisa Pieri, Tiziano Barbui, Timothy Devos, Paola Guglielmelli, Giorgina Specchia, Elisa Rumi, Margherita Maffioli, Mario Cazzola, Kiladjian Jean Jacques, Nicola Vianelli, Richard T. Silver, Rami S. Komrokji, Umberto Vitolo, Rambaldi Alessandro, Vannucchi Alessandro, Morra Enrica, Cristiana Pascutto, Valerio De Stefano, Barbara Mora, Cervantes Francisco, Francesco Passamonti, Marco Ruggeri
Publikováno v:
Blood. 124:1826-1826
Background. Polycythemia vera (PV) and essential thrombocythemia (ET) are chronic myeloproliferative neoplasms that can progress to secondary myelofibrosis (MF), named post-PV (PPV) MF and post-ET (PET) MF. While outcome of primary myelofibrosis is d